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The present study describes the development of theophylline microcapsules by a non-solvent addition 
method and the effect of plasticizer addition on microencapsulation. The release was studied in distilled 
water and the data were analysed by various mathematical models for determining the mechanism of 
release. Prepared microcapsules were found to be spherical, free flowing and having more than 80% 
entrapped drug. The polymer - cellulose acetate phthalate and plasticizer - polyethylene glycol was 
considered to be affecting the properties of microcapsules including drug release (time for 50% drug 
release, T50). The formulation with the highest proportion of polymer and without plasticizer (F3) 
showed the slowest release with T50 = 4.3 h, while the formulation with lower proportion of polymer 
and 20% (w/w) plasticizer (F13 &14) showed the fastest release of drug with T50 values of 1.2 h and 
1.3 h, respectively. The drug release from most of the formulations was found to be following Higuchi 
model. It is concluded from the results of the present study that cellulose acetate phthalate significantly 
affects the sustained release of the drug in water, whereas the addition of polyethylene glycol slightly 
enhances the drug release.
Uniterms: Theophylline/microcapsules. Microencapsulation. Cellulose acetate phthalate. Polyethylene 
glycol. Microcapsules/mechanism of release. Drugs/release.
O presente estudo descreve o desenvolvimento de microcápsulas de teofilina pelo método sem adição de 
solvente e o efeito da adição de plastificante na microencapsulação. A liberação foi estudada em água 
destilada e os dados foram analisados por vários modelos matemáticos para determinação do mecanismo 
de liberação. As microcápsulas preparadas mostraram-se esféricas, livres de corrente e com mais de 80% 
de fármaco encapsulado. O polímero - ftalato de acetato de celulose e o plastificante - polietileno glicol 
– afetaram as propriedades das microcápsulas, incluindo a liberação do fármaco (tempo para liberação 
de 50% do fármaco, T50). A formulação com a maior proporção de polímero e sem plastificante (F3) se 
mostrou como a de liberação mais lenta, com T50 = 4,3 h, enquanto as formulações com menor proporção 
de polímero e 20% de plastificante (m/m) (F13 &14) apresentaram a liberação mais rápida do fármaco, 
com T50 de 1,2 h e 1,3 h, respectivamente. A liberação do fármaco para a maioria das formulações seguiu 
o modelo de Higuchi. Concluiu-se, dos resultados do presente estudo, que o ftalato do acetato de celulose 
afeta significativamente a liberação controlada do fármaco em água, enquanto que a adição de polietileno 
glicol aumenta ligeiramente a liberação do fármaco. 
Unitermos: Teofilina/microcápsulas. Microencapsulação. Ftalato de acetato de celulose. Polietilenoglicol. 
Microcápsulas/mecanismo de liberação. Fármacos/liberação.
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INTRODUCTION
Theophylline is an effective bronchodilator used 
for the treatment of chronic asthma and obstructive lung 
disease (Hendeles, Weinberger, 1983). The drug is under 
a narrow therapeutic index and has rapid and uniform 
absorption throughout the gastrointestinal tract (Ly, 
1997). The conventionally used multiple dosing regimens 
of this drug results in adverse reactions that affect the 
gastrointestinal tract and the central nervous system. This 
is caused by the fluctuations of drug concentration in 
blood during the dosing intervals (Milavetz et al., 1984). 
Sustained-release theophylline formulations offer the 
advantage of less frequent dosing as well as minimum 
fluctuations in serum concentration during the dosing 
intervals as compared to conventional dosage forms. Thus, 
theophylline could be a candidate for a sustained release 
formulation.
The microencapsulation technique is an effective 
method for the preparation of oral sustained release 
dosage forms because the encapsulated drug is easier 
to administer and shows better compliance (Jalsenjak et 
al., 1976). Microcapsules are manufactured by various 
techniques including solvent-removal, hot-melt, solvent-
evaporation, spray-coating, pan-coating, spray drying, 
phase-separation and coacervation (Madan, 1978). The 
non-solvent addition method has been frequently used 
by many researchers because it offers several advantages 
over the others particularly, coacervation and spray drying 
(Pongpaibul and Whitworth, 1986). Moreover, it is less 
time consuming and can be done at room temperature 
in the absence of water, thus suitable for water-sensitive 
active pharmaceutical ingredients. 
For microencapsulation of drugs, cellulose acetate 
phthalate (CAP) has served as a polymer (Beyger and 
Nairn, 1986). It is an enteric polymer and is in need of 
a plasticizer in microencapsulation to improve its film 
forming characteristics. For such purposes, polyethylene 
glycol (PEG) is a frequently used (Rao, Diwan, 1997).
The present study was launched to prepare 
theophylline microcapsules using non-solvent addition 
method, and to evaluate the effect of different blends of the 




Anhydrous theophylline (Beijing Infoark Taee, 
China), polyethylene glycol 6000 (PEG-6000) and 
cellulose acetate phthalate (China) were obtained from 
Pacific Pharmaceuticals (Pvt.) Ltd. Lahore, Pakistan. 
Magnesium stearate (E. Merck, Germany) was obtained 
from Flow Pharmaceuticals (Pvt.) Ltd. Analytical grade 
acetone, n-hexane and liquid paraffin (E. Merck, Germany) 
were purchased from the local market.
Preparation of microcapsules
Fifteen microcapsule theophylline formulations 
were prepared according to the composition shown in 
Table I using a method described by (Ahmad et al., 2012) 
with some modifications. Briefly, the polymer solution 
was prepared by soaking 2.0 g of CAP in 15 mL of acetone 
for 1 h in a beaker, covered with aluminum foil to avoid 
solvent evaporation, and then the contents were stirred for 
10 to 15 min. A fixed amount (1.0 g) of theophylline was 
dispersed separately in varying amount of this polymer 
solution (Table I). Then each of the mixtures was mixed 
with 200 mL of liquid paraffin by stirring in a round bottom 
flask. The resulting dispersions were cooled to 10 °C. To 
each of the dispersions, 0.5 g of magnesium stearate was 
added while continuously stirring (locally made paddle) 
at 700 to 800 rpm to prevent aggregation. Then 30 mL 
of n-hexane (as non-solvent) was added to the above 
dispersions. After 5 min, microcapsules were separated by 
filtration and washed twice with 50 mL of n-hexane and 
dried overnight at room temperature in desiccators. In the 
formulations F4 to F15, PEG was added in CAP solution 
in a ratio of 10, 20, 30 and 40% (Table I). The PEG was 
added while stirring the polymer solution.
Determination of percentage yield
The yield of theophylline microcapsules was 
determined by the equation given as follows (Equation 1):
 Equation 1
Particle size
The sieve method was used to identify the 
particle size of the prepared theophylline microcapsule 
formulations. A group of sieves (20, 40, 60, 80, 100 and 
120 mesh size) were stacked and 10 g of microcapsules 
were placed on the top screen and vibrated mechanically 
for 10 min. The amount of microcapsules on each screen 
was determined by weighing and the mean particle size 
was calculated from the percentage weight retained and 
mean of openings of the sieve.
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Measurement of flowability
The angle of repose was measured using funnel 
with fixed-base cone. Carr’s index was established using 
the tapped and bulk density. The tapped density was 
determined by loading 2 g of microcapsules in a 10 mL 
measuring cylinder. The cylinder was tapped by dropping 
it three times freely from a height of 5 cm onto the desktop. 
The measured volume was recorded and bulk density 
was calculated using equation, d = m/v, where d, m and v 
are tapped density, weight and volume of microcapsules, 
respectively.
Determination of drug content
Standard stock solution (100 µg/mL) was prepared 
by dissolving 10 mg of theophylline in 10 mL of sodium 
hydroxide solution (0.1 N) in a 100 mL volumetric flask 
and then making up the volume with distilled water. The 
working standard solutions having a concentration 20, 
40, 60, and 80 μg/mL were prepared by diluting the stock 
solution with distilled water. 
Microcapsules of each formulation equivalent to 
10 mg were dissolved in 10 mL of sodium hydroxide 
solution (0.1 N) in a 100 mL volumetric flask and volume 
was made up with distilled water. The working sample 
solution of each of the samples was prepared by taking 
40 mL of the stock solution in a 100 mL volumetric flask 
and making up the volume with distilled water.
All the standard and sample solutions were analyzed 
in triplicate using spectrophotometer at 271.2 nm. The 
contents of theophylline of microcapsule formulations 
were determined from the calibration curve using the 
linear regression equation. 
In-vitro dissolution test
Dissolution tests were performed in 900 mL 
deionized water using USP basket method-II with rotation 
speed of 100 rpm at 37 ± 0.5°C. Microcapsules equivalent 
to 100 mg theophylline was placed into baskets. The 
aliquots of 10 mL were withdrawn at regular intervals 
(15, 30, 60, 90, 120, 150 min) and replaced with an equal 
volume of fresh medium. All the samples were filtered, 
diluted sufficiently and the UV absorbance was determined 
at λmax of 271.2 nm. All the samples were analyzed in 
triplicate (n =3) and the contents of theophylline were 
determined from the calibration curve.
Time for 50% of drug released (T50)
T50 - time taken by any formulation to release 50% 
of its active contents in the dissolution media - was based 
on the release profile of each formulation taking the time 
against 50% release.
Release kinetics analysis
Three kinetic models such as zero order (Equation.3), 
first order (Equation 4) and Higuchi model (Equation 5) 
were implemented to analyze in-vitro release data to 
find the equation which best described the data based on 
highest R2.
 Qt =K1t  Equation 2
 lnQt = ln Qo – K2t  Equation 3
 Q = K3 (t)0.5 Equation 4
where Q is release percentage at time t, and K1, K2 and K3 
are the rate constants of zero order, first order and Higuchi 
model, respectively.
For the mechanism of drug release, the Ritger-
Peppas model (Equation 6) was also employed (Higuchi, 
1963). 
 Mt/M∞ = ktn Equation 5
where Mt/M∞ is the fraction of drug released at time t, k is a 
TABLE I - Composition of formulations with drug, polymer and 
plasticizer
Formulation Polymer CAP. (g)
Plasticizer 
(g)
CAP to PEG 
Ratio
F1 1 0 1 : 0
F2 2 0 2 : 0
F3 3 0 3 : 0
F4 1 0.1 1 : 0.1
F5 2 0.1 2 : 0.1
F6 3 0.1 3 : 0.1
F7 1 0.2 1 : 0.2
F8 2 0.2 2 : 0.2
F9 3 0.2 3 : 0.2
F10 1 0.3 1 : 0.3
F11 2 0.3 2 : 0.3
F12 3 0.3 3 : 0.3
F13 1 0.4 1 : 0.4
F14 2 0.4 2 : 0.4
F15 3 0.4 3 : 0.4
CAP (cellulose acetate phthalate); PEG (polyethylene glycol)
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proportionality constant, which accounts for the structural 
and geometrical properties of the polymer matrix, and n is 
the diffusional exponent indicative of the mechanism of 
drug release (Washington, 1996).
RESULTS AND DISCUSSION
Microcapsules of theophylline were prepared using 
different blends of CAP as polymer and PEG as plasticizer. 
The yield of all formulations was above 75% (Table II). 
The developed microcapsules were characterized in term 
of particle size, density, flowability, drug content, release 
and time for 50% drug release (T50%).
Physical properties of formulations
The  phys ica l  p rope r t i e s  o f  theophy l l ine 
microcapsules have been provided in Table II. The 
particle size of formulations decreased upon increasing 
the polymer ratio in F1 to F3. The higher contents of the 
polymer increased in viscosity of polymeric solution 
producing smaller sized microcapsules. These findings are 
consistent with that reported earlier (Sanghvi, Nairn, 1991; 
Song et al., 2005). However, in formulations containing 
plasticizer (F4 to F15), the particle size increase (Table II) 
with the concentration of the plasticizer. This increase in 
particle size was caused by plasticizer induced moisture 
uptake by the polymer wall (Wan et al., 1993). The angle of 
repose ≤ 25º of all the microcapsules formulations indicate 
good flowability which is also depicted in the value of 
Carr index i.e. <15 in all microcapsule formulations. All 
the formulations have exhibited good drug entrapment 
efficiency, greater than 80% in all formulations, except 
F7 which might not be the real effect.
Drug release
Five standard solutions of theophylline were 
analysed in triplicate and the absorbance of these solutions 
was plotted against the respective concentration to 
construct the calibration curve. The linear regression 
equation determined from the calibration curve was found 
to be Y= 0.0047X + 0.0874 (R2 =0.9923). This equation 
was used to calculate the drug contents realsed from the 
microcapsule formulations at different time intervals. 
As shows in Figure1, the release of theophylline from 
microcapsules decreased gradually by increasing drug 
to polymer ratio of 1:1 to 1:3 in formulation F1 to F3 
(Figure 1). This effect is ascribed to the better covering of 
drug particles by the polymer (Goosen et al., 1985). The 
F3 showed only 12% release while F13 and F14 exhibited 
approximately 50% release in the first one hour. The 
formulations F13 and F14 released the drug most rapidly 
from all the microcapsule formulations (Figure 1). The 
inclusion of plasticizer produced channels in the polymer 
film of microcapsules (Palomo et al., 1996). In this study 














F1 1:1 0 318 0.476 79.2 4.55 20
F2 1:2 0 257 0.429 85.9 3.16 21
F3 1:3 0 266 0.512 97.9 2.50 22
F4 1:1 10 499 0.421 79.3 1.16 22
F5 1:2 10 512 0.481 87 3.49 23
F6 1:3 10 242 0.530 93 3.85 22
F7 1:1 20 320 0.487 73.2 3.53 23
F8 1:2 20 302 0.476 79.5 3.45 24
F9 1:3 20 297 0.434 92.4 4.17 23
F10 1:1 30 344 0.500 85.5 6.98 22
F11 1:2 30 289 0.487 78.5 4.65 25
F12 1:3 30 314 0.481 88 2.35 21
F13 1:1 40 394 0.465 80.9 6.52 22
F14 1:2 40 259 0.459 84.8 3.33 23
F15 1:3 40 266 0.454 92.8 2.22 23
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channeling effect of plasticizer caused the increased 
release from microcapsules. The time of 50% drug release 
was prolonged almost linearly with an increase in drug 
to polymer ratio from F1 to F3 (Table III). The higher 
amount of polymer provided thick coating thus caused 
slow release of drug (Jalil and Nixon, 1990). However, 
T50 for formulations containing plasticizer was found 
to be decreasing as compared to formulations without 
plasticizer. This was due to the swelling and hydration of 
the polymer film and development of pores on the wall 
of microcapsules secondary to leach of the plasticizer 
(Merkle, Speiser, 1973).
Kinetics analysis of release study
The release data were submitted to zero order, first 
order, Higuchi’s and Peppas model (Reddy et al., 2003, 
Wu et al., 2003). The release model parameters for all 
the formulations are shown in Table IV. The release of 
formulation F1 and F2 followed the Higuchi square root 
model with R2 values 0.9353 and 0.9134, respectively. The 
values of n from Peppas model for these formulations were 
0.2377 and 0.2968, respectively (n < 5), which indicated 
that the drug release for F1 and F2 followed the Fickian 
diffusion (Li et al., 2006, Hossain et al., 2007). The release 
from F3 followed zero order (R2 =0.9714) and the n value 
of Peppas model was 0.8068 (n > 5) which indicated a 
non-Fickian or anomalous release. These results were in 
agreement with the findings of previous studies (Ritger, 
Peppas, 1987; Majid Khan, Zhu, 1999).
The increase of 10 to 40% concentration of 
plasticizer in formulation F4 to F15 did not essentially 
FIGURE 1 - Drug release profile of different theophylline microcapsule formulations a) F1-F3 (no plasticizer) b) F4-F6 (10% 
plasticizer), c) F7-F9 (20% plasticizer), d) F10-F12 (30% plasticizer) e) F13-F15 (40% plasticizer).
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change the mechanism of drug release as all the 
formulations with drug to polymer ratio 1:1 and 1:2 (with 
or without plasticizer) followed the Higuchi model and 
the mechanism according to Peppas model was Fickian 
diffusion. The formulation with drug to polymer ratio 
1:3 (with or without plasticizer) followed the zero order 
release with non-Fickian or anomalous release mechanism.
It appeared that all the formulations followed 
the kinetics, which could not be explained by a single 
model. Kinetic profile during the first hour was usually 
the first order, which probably represented the non-
encapsulated fraction of drug. Then another profile 
(Higuchi or zero order) after 1 h indicated the release 
of the drug by diffusion, erosion or by the combination 
of both mechanisms as shown by ‘n’ values). Possibly 
there is more than one mechanism involved, and it 
seems that the effect of polymer concentration is more 
pronounced as compared to the percentage of plasticizer 
in each formulation. This argument is supported by the 
experimental data indicating more or less similar release 
profiles of the formulations (F3, F6, F9, F12 and F15) 
having an increasing concentration of the plasticizer and 
keeping drug to polymer ratio constant (1:3).
CONCLUSION
In this study, the microcapsules of theophylline 
were prepared using a non-solvent addition method. The 
microcapsules have shown better entrapment efficiency of 
drug and other processing properties. It is also concluded 
that the rate of drug release is inversely related to the 
polymer concentration. The addition of plasticizer slightly 
enhances the drug release.
TABLE III - Time for 50% drug release and cumulative %age of 
drug released in 6 h
Formulation T50 (h) (±SD)
Total drug released 
in 6 h (%)
F1 2.4 ± 0.1 81
F2 3.2 ± 0.15 69
F3 4.8 ± 0.2 56
F4 2.2 ± 0.1 81
F5 2.8 ± 0.1 77
F6 4.2 ± 0.2 64
F7 2.4 ± 0.15 82
F8 2.6 ± 0.15 81
F9 3.6 ± 0.2 71
F10 2.2 ± 0.1 84
F11 2.4 ± 0.1 83
F12 3.6 ± 0.15 75
F13 1.2 ± 0.1 84
F14 1.3 ± 0.1 85
F15 3.4 ± 0.2 78
TABLE IV - Kinetic values obtained from different plots of theophylline microcapsule formulations
Formulation
Zero order First order Higuchi Peppas
K R2 K R2 K R2 n R2
F1 12.335 0.807 0.4739 0.4758 35.356 0.9353 0.2377 0.9054
F2 10.299 0.777 0.4672 0.4804 29.729 0.9134 0.2968 0.9445
F3 9.63 0.9714 0.5535 0.699 25.387 0.953 0.8068 0.9909
F4 12.235 0.7561 0.4714 0.4585 35.748 0.9106 0.2519 0.948
F5 11.462 0.8072 0.4839 0.4944 32.64 0.9224 0.2534 0.8306
F6 11.658 0.9808 0.5756 0.7416 30.09 0.9218 0.9395 0.9811
F7 12.46 0.7741 0.4788 0.4697 36.086 0.9161 0.2422 0.8456
F8 12.551 0.8226 0.499 0.5041 35.355 0.9314 0.3046 0.9062
F9 12.426 0.9889 0.554 0.707 32.188 0.9362 0.8967 0.9876
F10 12.678 0.7909 0.471 0.4634 36.718 0.9359 0.3442 0.931
F11 12.853 0.7903 0.4937 0.4862 36.986 0.9234 0.3089 0.9068
F12 12.285 0.9804 0.5362 0.6653 32.274 0.9547 0.7803 0.9845
F13 12.573 0.7504 0.4689 0.4512 36.952 0.9145 0.4001 0.9789
F14 12.332 0.6866 0.4802 0.4452 36.719 0.8588 0.1717 0.8501
F15 13.4 0.9825 0.5369 0.6555 34.64 0.9532 0.7594 0.9614
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